United States · Funded startup

Who invested in Excelimmune

5 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$34Mraised across 5 rounds since 2010, from 5 sources

$11MSeries B$12MSeries C
Latest round
Debt, $6.0MJan 2012
Biggest round
$12MSeries C · Dec 2011
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112012
$1.0MSeries B$4.5MVenture$11MSeries B$12MSeries C$6.0MDebt
First round
Series B, $1.0M
Apr 2010
Biggest round
$12M
Series C · Dec 2011
Usual gap between rounds
7 months
the median of 3

The rounds

  1. Jan 2012
    Debt$6.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $6.0M sold, first sale Dec 2011

  2. Dec 2011
    Series C$12M

    No investor was named in the report.

    Reported by finsmes.comSEC filing: $6.0M sold, first sale Dec 2011

  3. May 2011
    Series B$11M

    No investor was named in the report.

    Reported by masshightech.com

  4. Jul 2010
    Venture$4.5M

    No investor was named in the report.

    Reported by fiercebiotech.comSEC filing: $4.5M sold, first sale Jun 2010

  5. Apr 2010
    Series B$1.0M

    No investor was named in the report.

    Reported by onbiovc.comSEC filing: $4.5M sold, first sale Jun 2010

Funding filed with regulators

Excelimmune filed 2 raises, $10M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Dec 2011$6.0M1 investordebt, securities on exerciseof $12M offeredSEC Form D
  2. Jun 2010$4.5M2 investorsequityof $9.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 2 on the team.

  • Quinton Y. ZondervanExecutive Officer, Directori
  • Vincent Y. ColjeeExecutive Officer, Directori

On the board, as filediKaroly Y. NikolichScott Y. Hassan

Quick answers about Excelimmune

How much has Excelimmune raised?

Excelimmune has raised $34M across 5 rounds since 2010.

When did Excelimmune last raise?

Excelimmune's most recent round was a Debt of $6.0M in Jan 2012.

What was Excelimmune's biggest round?

Excelimmune's largest round on record is $12M (Series C), in Dec 2011.

What stage is Excelimmune at?

Excelimmune's latest named round is a Debt, in Jan 2012.

Where is Excelimmune based?

Excelimmune is based in the United States.

Companies like Excelimmune

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.